Ionis Pharmaceuticals, Inc. (IONS)
42.93
-0.98
(-2.23%)
USD |
NASDAQ |
Oct 23, 16:00
42.91
-0.02
(-0.05%)
After-Hours: 20:00
Ionis Pharmaceuticals Market Cap : 7.111B for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 7.111B |
| October 22, 2026 | 7.273B |
| October 21, 2026 | 7.333B |
| October 20, 2026 | 7.520B |
| October 19, 2026 | 7.351B |
| October 16, 2026 | 7.112B |
| October 15, 2026 | 7.308B |
| October 14, 2026 | 7.073B |
| October 13, 2026 | 7.020B |
| October 12, 2026 | 7.233B |
| October 09, 2026 | 7.500B |
| October 08, 2026 | 7.172B |
| October 07, 2026 | 7.315B |
| October 06, 2026 | 7.288B |
| October 05, 2026 | 7.205B |
| October 02, 2026 | 7.212B |
| October 01, 2026 | 7.288B |
| September 30, 2026 | 7.396B |
| September 29, 2026 | 7.601B |
| September 28, 2026 | 7.548B |
| September 25, 2026 | 7.371B |
| September 24, 2026 | 7.257B |
| September 23, 2026 | 7.276B |
| September 22, 2026 | 7.578B |
| September 21, 2026 | 7.437B |
| Date | Value |
|---|---|
| September 18, 2026 | 7.361B |
| September 17, 2026 | 7.744B |
| September 16, 2026 | 7.427B |
| September 15, 2026 | 7.826B |
| September 14, 2026 | 8.520B |
| September 11, 2026 | 8.979B |
| September 10, 2026 | 9.218B |
| September 09, 2026 | 9.279B |
| September 08, 2026 | 9.393B |
| September 04, 2026 | 9.622B |
| September 03, 2026 | 9.628B |
| September 02, 2026 | 10.16B |
| September 01, 2026 | 9.918B |
| August 31, 2026 | 9.998B |
| August 28, 2026 | 10.11B |
| August 27, 2026 | 10.34B |
| August 26, 2026 | 10.49B |
| August 25, 2026 | 10.53B |
| August 24, 2026 | 10.28B |
| August 21, 2026 | 9.895B |
| August 20, 2026 | 9.733B |
| August 19, 2026 | 10.07B |
| August 18, 2026 | 9.875B |
| August 17, 2026 | 9.711B |
| August 14, 2026 | 9.481B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Alnylam Pharmaceuticals, Inc. | 29.96B |
| Biogen, Inc. | 37.03B |
| BridgeBio Pharma, Inc. | 13.39B |
| Vertex Pharmaceuticals, Inc. | 132.74B |
| Amgen, Inc. | 237.46B |
Market Cap Related Metrics
| PS Ratio | 8.009 |
| PEG Ratio | -0.1412 |
| Price to Book Value | 16.17 |
| Price | 42.93 |
| Earnings Yield | -8.09% |
| PEGY Ratio | -0.1412 |